Question

3 — pharmacological interventions for weight loss
learning objective: distinguish between potential benefits or risks related to pharmacological weight loss management strategies.

why might someone who is pregnant or planning to become pregnant want to avoid taking qsymia?

a.) qsymia promotes abnormal weight gain in a fetus.
b.) qsymia contains topiramate, which is associated with an increased risk of birth defects.
c.) qsymia interferes with the bodys ability to absorb essential vitamins.
d.) qsymia decreases the mothers heart rate, leading to complications.

Explanation:

Qsymia is a weight - loss drug. One of its components is topiramate. Medical research has shown that topiramate is linked to a higher risk of birth defects. Option a is incorrect because Qsymia is for weight loss and not related to promoting fetal weight gain. Option c is wrong as there's no evidence that Qsymia interferes with vitamin absorption in a way relevant to pregnancy avoidance. Option d is incorrect as Qsymia doesn't primarily act by decreasing the mother's heart rate to cause complications related to pregnancy avoidance. So the correct answer is b.

Answer:

b.) Qsymia contains topiramate, which is associated with an increased risk of birth defects.